PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Positive revenue growth while INTC is negative. John Neff might see a notable competitive edge here.
1.44%
Positive gross profit growth while INTC is negative. John Neff would see a clear operational edge over the competitor.
10.06%
Positive EBIT growth while INTC is negative. John Neff might see a substantial edge in operational management.
9.27%
Positive operating income growth while INTC is negative. John Neff might view this as a competitive edge in operations.
-7.68%
Negative net income growth while INTC stands at 27.89%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.85%
Negative EPS growth while INTC is at 29.03%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.00%
Negative diluted EPS growth while INTC is at 30.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-5.29%
Share reduction while INTC is at 0.10%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.04%
Reduced diluted shares while INTC is at 0.37%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
8.69%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
-58.68%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-152.53%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
43.68%
10Y revenue/share CAGR under 50% of INTC's 541.00%. Michael Burry would suspect a lasting competitive disadvantage.
-12.20%
Negative 5Y CAGR while INTC stands at 134.60%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
14.04%
3Y revenue/share CAGR at 50-75% of INTC's 21.55%. Martin Whitman would question if the firm lags behind competitor innovations.
322.80%
10Y OCF/share CAGR under 50% of INTC's 1872.86%. Michael Burry would worry about a persistent underperformance in cash creation.
57.02%
Below 50% of INTC's 351.89%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
29.13%
3Y OCF/share CAGR at 50-75% of INTC's 44.79%. Martin Whitman would suspect weaker recent execution or product competitiveness.
2488.56%
Net income/share CAGR above 1.5x INTC's 1244.91% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
66.59%
Below 50% of INTC's 216.61%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
205.05%
3Y net income/share CAGR above 1.5x INTC's 33.31%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
261.53%
Below 50% of INTC's 845.03%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
211.41%
5Y equity/share CAGR at 75-90% of INTC's 276.65%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
147.24%
3Y equity/share CAGR 1.25-1.5x INTC's 106.92%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
16.57%
Dividend/share CAGR of 16.57% while INTC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
38.50%
Below 50% of INTC's 317.60%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
2.24%
Below 50% of INTC's 139.16%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
0.10%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.81%
Inventory growth well above INTC's 3.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.45%
Asset growth above 1.5x INTC's 9.04%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
27.76%
BV/share growth above 1.5x INTC's 10.85%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.41%
We’re deleveraging while INTC stands at 4.73%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
18.99%
R&D growth drastically higher vs. INTC's 8.44%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.83%
We cut SG&A while INTC invests at 1.72%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.